Skip to main content

Table 1 Participant characteristics

From: Can a physical activity program improve functional capacity and fatigue in people with cancer? A retrospective analysis

 

All participants

 

Participants who completed the program

 

Participants who dropped out of the program

  

Characteristics

Values

n

Values

n

Values

n

p-value

finishers vs. drop-out

Age, (years)

57.36 ± 12.43 (18–89)

263

58.21 ± 11.49 (31–89)

125

56.59 ± 13.22 (18–88)

138

0.292

 Age women

56.22 ± 12.17 (18–88)

188

56.63 ± 11.13 (31–81)

99

55.76 ± 13.28 (18–88)

89

0.629

 Age men

60.21 ± 12.69 (23–89)

75

64.23 ± 11.00 (40–89)

26

58.08 ± 13.11 (23–74)

49

0.045

Gender, n (%)

 

264

 

125

 

139

 

 Women

189 (72)

189

99 (79)

99

90 (65)

90

 

 Men

75 (28)

75

26 (21)

26

49 (35)

49

 

Height, (cm)

164.93 ± 9.61 (147–202)

149

163.17 ± 8.17 (147–186)

69

166.45 ± 10.51 (150–202)

80

0.037

 Height women

160.76 ± 6.56 (147–178)

106

160.67 ± 6.43 (147–176)

55

160.84 ± 6.76 (150–178)

51

0.895

 Height men

175.23 ± 8.05 (163–202)

43

173.00 ± 6.82 (163–186)

14

176.31 ± 8.48 (163–202)

29

0.210

Weight, (kg)

73.63 ± 18.09 (42–174)

150

71.57 ± 16.42 (42–120)

69

75.38 ± 19.33 (43–174)

81

0.199

 Weight women

69.29 ± 16.24 (42–105)

107

67.80 ± 14.96 (42–102)

55

70.88 ± 17.50 (43–105)

52

0.330

 Weight men

84.41 ± 18.14 (60–174)

43

86.36 ± 13.62 (67–120)

14

83.47 ± 20.12 (60–174)

29

0.630

BMI, (kg/m2)

27.04 ± 5.97 (16.16–58.14)

149

26.74 ± 5.13 (16.16–39.35)

69

27.30 ± 6.64 (17.16–58.14)

80

0.569

 BMI women

26.85 ± 6.02 (16.16–45.33)

106

26.21 ± 5.31 (16.16–39.35)

55

27.54 ± 6.70 (17.16–45.33)

51

0.259

 BMI men

27.52 ± 5.88 (19.82–58.14)

43

28.83 ± 3.82 (20.68–34.69)

14

26.89 ± 6.63 (19.82–58.14)

29

0.317

Cancer type, n (%)

 

264

 

125

 

139

 

 Appendix

1 (< 1)

 

1 (1)

 

0

  

 Bladder

2 (1)

 

1 (1)

 

1 (1)

  

 Bone

1 (< 1)

 

0

 

1 (1)

  

 Breast

134 (51)

 

76 (61)

 

58 (42)

  

 Brain

9 (3)

 

3 (2)

 

6 (4)

  

 Brain lymphoma

1 (< 1)

 

0

 

1 (1)

  

 Colorectal

18 (7)

 

9 (7)

 

9 (7)

  

 Gall bladder

2 (1)

 

1 (1)

 

1 (1)

  

 Gynecological

14 (5)

 

4 (3)

 

10 (7)

  

 Kidney

3 (1)

 

1 (1)

 

2 (1)

  

 Leukemia

4 (2)

 

3 (2)

 

1 (1)

  

 Liver

3 (1)

 

1 (1)

 

2 (1)

  

 Lung

23 (9)

 

8 (6)

 

15 (11)

  

 Lymphoma

8 (3)

 

2 (2)

 

6 (4)

  

 Mediastinum

1 (< 1)

 

0

 

1 (1)

  

 Oesophagus

2 (1)

 

0

 

2 (1)

  

 ORL

6 (2)

 

2 (2)

 

4 (3)

  

 Pancreas

6 (2)

 

2 (2)

 

4 (3)

  

 Prostate

11 (4)

 

6 (6)

 

5 (4)

  

 Skin

4 (2)

 

2 (2)

 

2 (2)

  

 Small intestine

1 (< 1)

 

0

 

1 (1)

  

 Spleen

1 (< 1)

 

1 (1)

 

0

  

 Stomach

7 (3)

 

2 (2)

 

5 (4)

  

 Thyroid

2 (1)

 

0

 

2 (1)

  

Therapy, n (%)

 

232

 

105

 

127

 

 C

39 (15)

 

15 (14)

 

24 (19)

  

 C + S

26 (10)

 

10 (10)

 

16 (13)

  

 C + S + H

2 (1)

 

1 (1)

 

1 (1)

  

 C + S + H + R

9 (3)

 

6 (6)

 

3 (2)

  

 C + S + I

2 (1)

 

1 (1)

 

1 (1)

  

 C + S + I + R

5 (2)

 

2 (2)

 

3 (2)

  

 C + S + R

34 (13)

 

19 (18)

 

15 (12)

  

 C + H

4 (2)

 

2 (2)

 

2 (2)

  

 C + H + I

1 (< 1)

 

0

 

1 (1)

  

 C + H + R

10 (4)

 

5 (5)

 

5 (4)

  

 C + I

4 (2)

 

0

 

4 (3)

  

 C + I + R

2 (1)

 

1 (1)

 

1 (1)

  

 C + R

26 (10)

 

8 (8)

 

18 (14)

  

 S

13 (5)

 

9 (9)

 

4 (3)

  

 S + H

6 (2)

 

4 (4)

 

2 (2)

  

 S + H + I + R

1 (< 1)

 

1 (1)

 

0

  

 S + H + R

14 (5)

 

9 (9)

 

5 (4)

  

 S + I

1 (< 1)

 

0

 

1 (1)

  

 S + R

12 (5)

 

4 (4)

 

8 (6)

  

 H

4 (2)

 

2 (2)

 

2 (2)

  

 H + R

5 (2)

 

1 (1)

 

4 (3)

  

 I

8 (3)

 

3 (3)

 

5 (4)

  

 R

1 (< 1)

 

0

 

1 (1)

  

 None

3 (1)

 

2 (2)

 

1 (1)

  
  1. Socio-demographics and clinical characteristics of participants. Data are mean ± SD (Min–Max) or n (%)
  2. BMI Body Mass Index, C Chemotherapy, H Hormone therapy, I Immune therapy, ORL Otorhinolaryngological, R Radiation therapy, S Surgery
  3. In bold, p-value < 0.05